XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 30.14

-3.3%

12:06 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (7727)	11/13/1998 11:43:00 AM
From: aknahow	Read Replies (3) of 17367

Employing firms to seek out partner and licensing agreements, has this been done before? Sort of think it has. Anyone remember the details? Does this disclosure mean anything? Note they are not seeking a strategic relationship "partner" for I-Prex but rather firms interested in licensing. Question, it is not even an approved drug, so what does a license agreement mean? Thoughts, pro/con? "XOMA scientists recently presented the first data demonstrating oral availability of its Mycoprex(TM) fungicidal compounds at ICAAC; the Company has engaged Vector Securities International, Inc. as advisor for pursuing a strategic relationship with a pharmaceutical company partner for Mycoprex(TM). Similarly, LM&E Company Advisors (an ophthalmic consulting company) is assisting XOMA in licensing efforts for the I-PREX(TM) topical ophthalmic product."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next